Advanced search
Publication Cover
Scandinavian Journal of Rheumatology Volume 48, 2019 - Issue 2
Submit an article Journal homepage
619
Views
15
CrossRef citations to date
0
Altmetric
Articles

Adalimumab versus adalimumab and methotrexate for the treatment of juvenile idiopathic arthritis: long-term data from the German BIKER registry

A KleinDepartment of Paediatrics, Centre for Paediatric Rheumatology, Asklepios Clinic Sankt Augustin, Sankt Augustin, Germany;Medical Faculty, University of Cologne, Cologne, GermanyCorrespondence[email protected]
View further author information
,
I BeckerInstitute of Medical Statistics and Computational Biology, University of Cologne, Cologne, GermanyView further author information
,
K MindenGerman Rheumatism Research Centre Berlin, and Charité University Medicine, Berlin, GermanyView further author information
,
I FoeldvariHamburg Centre of Paediatric and Adolescent Rheumatology, Hamburg, GermanyView further author information
,
JP HaasGerman Centre for Paediatric and Adolescent Rheumatology, Garmisch-Partenkirchen, GermanyView further author information
&
G HorneffDepartment of Paediatrics, Centre for Paediatric Rheumatology, Asklepios Clinic Sankt Augustin, Sankt Augustin, Germany;Medical Faculty, University of Cologne, Cologne, GermanyView further author information
Pages 95-104 | Accepted 09 Jun 2018, Published online: 09 Nov 2018

Citations (15)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Ilaria Maccora, Maria Pia dell’Anna, Alfredo Vannacci & Gabriele Simonini. (2020) Safety evaluations of adalimumab for childhood chronic rheumatic diseases. Expert Opinion on Drug Safety 19:6, pages 661-671.
Read now

Articles from other publishers (14)

Tatjana Welzel, Klervi Golhen, Andrew Atkinson, Verena Gotta, David Ternant, Jasmin B. Kuemmerle-Deschner, Christine Michler, Gilbert Koch, Johannes N. van den Anker, Marc Pfister & Andreas Woerner. (2024) Prospective study to characterize adalimumab exposure in pediatric patients with rheumatic diseases. Pediatric Rheumatology 22:1.
Crossref
Fatma Gül DEMİRKAN & Nuray AKTAY AYAZ. (2023) Comparison of biologic monotherapy versus biologic and disease-modifying anti-rheumatic drug combination in the treatment of non-systemic juvenile idiopathic arthritisSistemik olmayan juvenil idiyopatik artrit tedavisinde biyolojik monoterapi ile biyolojik ve hastalık modifiye edici anti-romatizmal ilaç kombinasyonunun karşılaştırılması. Turkish Journal of Pediatric Disease, pages 406-412.
Crossref
Franz Thiele, Ariane Klein, Jens Klotsche, Daniel Windschall, Frank Dressler, Jasmin Kuemmerle-Deschner, Kirsten Minden, Ivan Foeldvari, Dirk Foell, Sonja Mrusek, Prasad Thomas Oommen & Gerd Horneff. (2023) Biologics with or without methotrexate in treatment of polyarticular juvenile idiopathic arthritis: effectiveness, safety and drug survival. Rheumatology 62:6, pages 2230-2238.
Crossref
Lily Siok Hoon Lim, Armend Lokku, Eleanor Pullenayegum & Sarah Ringold. (2023) Probability of Response in the First Sixteen Weeks After Starting Biologics: An Analysis of Juvenile Idiopathic Arthritis Biologics Trials. Arthritis Care & Research 75:6, pages 1238-1249.
Crossref
Manuel Busto-Iglesias, Lorena Rodríguez-Martínez, Carmen Antía Rodríguez-Fernández, Jaime González-López, Miguel González-Barcia, Begoña de Domingo, Luis Rodríguez-Rodríguez, Anxo Fernández-Ferreiro & Cristina Mondelo-García. (2023) Perspectives of Therapeutic Drug Monitoring of Biological Agents in Non-Infectious Uveitis Treatment: A Review. Pharmaceutics 15:3, pages 766.
Crossref
Emmanuel Mahé, Alain Beauchet, Smaïl Hadj‐Rabia, Juliette Mazereeuw‐Hautier, Stéphanie Mallet, Alice Phan, Maëlle Severino‐Freire, Franck Boralevi, Hélène Aubert, Hugue Barthélémy, Céline Girard, Ludovic Martin, Maryam Piram, Sébastien Barbarot, Xavier Balguerie, Jinane Zitouni, Céline Phan & Vito Di Lernia. (2022) Biologics combined with conventional systemic agents for the treatment of children with severe psoriasis. Real‐life data from the BiPe cohorts and a practice survey among French and Italian pediatric dermatologists. Dermatologic Therapy 35:11.
Crossref
Mehul P. Jariwala & Sujata Sawhney. 2022. Handbook of Biologics for Rheumatological Disorders. Handbook of Biologics for Rheumatological Disorders 165 178 .
Gerd Horneff, Kirsten Minden, Dirk Föll & Günther Dannecker. 2022. Pädiatrische Rheumatologie. Pädiatrische Rheumatologie 365 391 .
Rachel L. Randell & Mara L. Becker. (2021) Safety updates in novel therapeutics for pediatric rheumatic disease. Current Opinion in Rheumatology 33:5, pages 403-408.
Crossref
Franz Thiele, Ariane Klein, Daniel Windschall, Anton Hospach, Ivan Foeldvari, Kirsten Minden, Frank Weller-Heinemann & Gerd Horneff. (2021) Comparative risk of infections among real-world users of biologics for juvenile idiopathic arthritis: data from the German BIKER registry. Rheumatology International 41:4, pages 751-762.
Crossref
Gerd Horneff, Kirsten Minden, Dirk Föll & Günther Dannecker. 2020. Pädiatrische Rheumatologie. Pädiatrische Rheumatologie 1 27 .
N. Ghalandari, R. J. E. M. Dolhain, J. M. W. Hazes, E. P. van Puijenbroek, M. Kapur & H. J. M. J. Crijns. (2020) Intrauterine Exposure to Biologics in Inflammatory Autoimmune Diseases: A Systematic Review. Drugs 80:16, pages 1699-1722.
Crossref
Nadine Saad & Karen Onel. (2020) Overview of Juvenile Idiopathic Arthritis. The Open Orthopaedics Journal 14:1, pages 101-109.
Crossref
Ariane Klein. (2019) Biologikabehandlung bei der juvenilen idiopathischen ArthritisBiologics in the treatment of juvenile idiopathic arthritis. Zeitschrift für Rheumatologie 78:7, pages 599-609.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.